Sanofi (SNYNF)

OTCMKTS · Delayed Price · Currency is USD

94.35

-0.40 (-0.42%)

Dec 23, 2024, 3:00 PM EST

Sanofi Employees

Sanofi had 86,088 employees as of December 31, 2023. The number of employees decreased by 5,485 or -5.99% compared to the previous year.

Employees

86,088

Change (1Y)

-5,485

Growth (1Y)

-5.99%

Revenue / Employee

$627,636

Profits / Employee

$58,378

Market Cap

119.50B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	86,088	-5,485	-5.99%
Dec 31, 2022	91,573	-3,869	-4.05%
Dec 31, 2021	95,442	-3,970	-3.99%
Dec 31, 2020	99,412	-997	-0.99%
Dec 31, 2019	100,409	-3,817	-3.66%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Related Stocks

Company Name	Employees
Sandoz Group AG	22,633
Telix Pharmaceuticals Limited	234
Elekta AB (publ)	4,718
Ryman Healthcare Limited	7,700
Verano Holdings Corp.	3,900
Vireo Growth Inc.	490
Medexus Pharmaceuticals Inc.	82

Employee Rankings

Sanofi News

1 day ago - Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines - GlobeNewsWire
2 days ago - Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio? - Benzinga
4 days ago - Sanofi to buy China rights to Cytokinetics lead asset - Seeking Alpha
4 days ago - Cytokinetics Inc (CYTK) Announces Sanofi's Acquisition of Aficamten Rights in Greater China - GuruFocus
5 days ago - Presse release: Jean-Paul Kress to join Sanofi's Board of Directors - GlobeNewsWire
6 days ago - Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases - Benzinga
6 days ago - Sanofi and Teva Achieve Milestone in Ulcerative Colitis Treatment Study - GuruFocus
7 days ago - Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's - Investopedia